Live Breaking News & Updates on Timothy Eugene Sullivan|Page 3
Stay updated with breaking news from Timothy eugene sullivan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts Set Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Target Price at $78.60 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report)’s share price fell 3.3% during mid-day trading on Monday . The stock traded as low as $54.07 and last traded at $54.07. 120,819 shares were traded during trading, a decline of 92% from the average session volume of 1,495,266 shares. The stock had previously closed at $55.91. […] ....
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) was the recipient of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 10,590,000 shares, a growth of 5.3% from the February 29th total of 10,060,000 shares. Based on an average trading volume of 1,580,000 shares, […] ....
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) CFO Timothy Eugene Sullivan sold 4,000 shares of Apellis Pharmaceuticals stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $58.66, for a total transaction of $234,640.00. Following the completion of the sale, the chief financial officer now […] ....
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) CFO Timothy Eugene Sullivan sold 4,000 shares of Apellis Pharmaceuticals stock in a transaction on Monday, April 1st. The stock was sold at an average price of $58.66, for a total transaction of $234,640.00. Following the sale, the chief financial officer now directly owns 93,338 shares of […] ....